Evidence map›Paper›PMID 34337546›Full record

ArticleEuropean urology open science2021

Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative.

Amit K Patel, Brian R Lane, Prateek Chintalapati, Lina Fouad, Mohit Butaney, Jeffrey Budzyn, Anna Johnson, Ji Qi, Edward Schervish, Craig G Rogers

Open access · goldAbstract read
In one paragraph

Article in European urology open science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The evolving management of small renal masses.Nature reviews. Urology · 2024
    Review
  9. Article
  10. Clinical safety and efficacy of microwave ablation for small renal masses.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Amit K PatelHenry Ford Health System, Detroit, MI, USA.
Brian R LaneMichigan State University College of Human Medicine, Grand Rapids, MI, USA.
Prateek ChintalapatiWayne State School of Medicine, Detroit, MI, USA.
Lina FouadWayne State School of Medicine, Detroit, MI, USA.
Mohit ButaneyHenry Ford Health System, Detroit, MI, USA.
Jeffrey BudzynHenry Ford Health System, Detroit, MI, USA.
Anna JohnsonDepartment of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.
Ji QiDepartment of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.
Edward SchervishMichigan Institute of Urology, Troy, MI, USA.
Craig G RogersHenry Ford Health System, Detroit, MI, USA.
Henry Ford Health System · USUniversity of Michigan–Ann Arbor · USWayne State University · USMichigan Institute of Urology · USMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal mass biopsy (RMB) has had limited and varied utilization to guide management of renal masses (RM).

objectiveTo evaluate utilization of RMB for newly diagnosed cT1 RMs across diverse practice types and assess associations of outcomes with RMB. DESIGN SETTING AND

participantsMUSIC-KIDNEY commenced data collection in September 2017 for all newly presenting patients with a cT1 RM at 14 diverse practices. Patients were assessed at ≥120 d after initial evaluation. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Demographics and outcomes were compared for patients undergoing RMB versus no RMB. Clinical and demographic characteristics were summarized by RMB status using a χ RESULTS AND LIMITATIONS: RMB was performed in 15.5% (

conclusionsUtilization of RMB varied widely across practices. Factors associated with RMB include comorbidities and lesion type. Patients undergoing RMB were less likely to have benign histology at intervention. PATIENT SUMMARY: Current use of biopsy for kidney tumors is low and varies across our collaborative. Biopsy was performed in patients with greater comorbidity (more additional medical conditions) and for solid kidney tumors. Pretreatment biopsy is associated with lower nonmalignant pathology detected at treatment.

Indexed as

Partial nephrectomyPathologyRenal cell carcinomaRenal mass biopsySmall renal mass

Identifiers

PMID34337546
PMCPMC8317904
OpenAlexW3173243675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.